Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Solid Tumor 2Stomach Neoplasms 1Solid Tumor Cancer 1Refractory Solid Tumors 1Pseudomyxoma Peritonei 1Neoplasms, Cystic, Mucinous, and Serous 1Mesothelioma 1Malignant Solid Neoplasm 1Colorectal Neoplasms 1Advanced Solid Tumors 1Adenocarcinoma, Mucinous 1

Interventions

Injections 27Carboplatin 18Docetaxel 14pembrolizumab 13Paclitaxel 12Bevacizumab 10durvalumab 8Nivolumab 8Cisplatin 8Fluorouracil 7Pemetrexed 6Oxaliplatin 6Leucovorin 6trifluridine tipiracil drug combination 5toripalimab 5tislelizumab 5linifanib 5Capecitabine 5zimberelimab 4talazoparib 4olaparib 4fludarabine 4Panobinostat 4Itraconazole 4Irinotecan 4Gemcitabine 4Everolimus 4tremelimumab 3sotorasib 3sintilimab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Advanced Solid Tumors × irinotecan sucrosofate × Other solid neoplasm × Clear all
NCT05086822 2021-10-21

A Study of Irinotecan Hydrochloride Liposome in Advanced Solid Tumors

Jiangsu HengRui Medicine Co., Ltd.

Phase 1 Completed
32 enrolled
Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡